Can smarter surveillance sharpen pneumonia vaccines?
NCT ID NCT04447521
First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time
Summary
This study observes people in Belgium with non-invasive pneumococcal infections like pneumonia, ear infections, and sinusitis. Researchers will collect bacterial samples to see which strains are circulating and how they compare to invasive infections. The goal is to understand how well current vaccines are working and whether adjustments are needed.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- This surveillance could help refine vaccination programs to better protect against pneumonia, ear infections, and sinusitis.
- What could go wrong
- As an observational study, it won't test a new treatment. Findings may not directly change policy without further research.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OTITIS MEDIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sciensano
Brussels, 1180, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a tiny ear tube offer lasting relief for middle ear infections?
- AI could outsmart bacteria: a smarter way to choose antibiotics?
- Breathing technique may outperform spirometry for smog pneumonia recovery
- A gentle touch against coughs and colds: could manual therapy shorten respiratory illness?
- Can a smart oxygen device shorten hospital stays for pneumonia?
- Could everyday supplements shield your lungs?